New Issue: Science’s Impossible Questions. Read Now

30 under 30: Designing New Ways to Stop Tumors

Meet Nadja Bertleff, one of the promising young chemists attending the 2013 Lindau Nobel Laureate Meeting

Join Our Community of Science Lovers!

Each year hundreds of the best and brightest researchers gather in Lindau, Germany, for the Nobel Laureate Meeting. There, the newest generation of scientists mingles with Nobel Prize winners and discusses their work and ideas. The 2013 meeting is dedicated to chemistry and will involve young researchers from 78 different countries. In anticipation of the event, which will take place from June 30 through July 5, we are highlighting a group of attendees under 30 who represent the future of chemistry. The following profile is the 16th in a series of 30.

Name: Nadja Bertleff
Age: 27
Born: Heidelberg, Germany
Nationality: German

Current position: PhD student at the Institute for Organic Chemistry at the University of Würzburg in Germany
Education: Master’s degree in chemistry from the University of Würzburg


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


What is your field of research?
I am designing and synthesizing carbohydrate-based inhibitors for the tumor-associated protein galectin-1. My research project is highly interdisciplinary and includes techniques from organic synthesis, biochemistry, protein crystallization, and computational chemistry.

What drew you to chemistry, and to that research area in particular?
Early on, I was inspired by renowned research centers such as the European Molecular Biology Laboratory and the German Cancer Research Center, both in Heidelberg, my birthplace. I became fascinated by biological and physiological processes on a molecular level and by the idea of better understanding these complex events. From the chemist’s perspective, the design and synthesis of tailor-made compounds to address and interfere with the severe malfunctions inherent in diseases seemed enormously challenging. I enjoy working at the intersection of chemistry, biology and medicine in my current position. I also benefit greatly from discussions and collaborations with colleagues from diverse scientific backgrounds.

Where do you see yourself in 10 years?
I hope that I will continue to work in a stimulating atmosphere with people around me that inspire and encourage me to question complex issues. In 10 years I see myself leading my own group in an interdisciplinary research center and working on the biggest life science questions of our generation.

Who are your scientific heroes?
I look up to scientists who pursue their research with enthusiasm, who are open-minded for new ideas and techniques, who inspire young fellows, and are socially responsible. Linus Pauling is one of these heroes, and I admire his contributions to the nature of the chemical bond and elucidation of its structure as well as his activism against war and nuclear weapons tests.

What activities outside of chemistry do you most enjoy?
I love to travel around the world and discover new places. The most impressive experiences I’ve had were touring New Zealand in a camper and traveling through the volcanic and glacier-covered landscape of Iceland.

What do you hope to gain from this year’s Lindau meeting?
In Lindau I will meet investigators that were awarded with the most renowned prize in science—the Nobel Prize! I am excited to learn more about their research, obstacles and successes in their academic careers. I am extremely curious about their predictions on how research will develop in the future and how scientific responsibility should be practiced. I am looking forward to the stimulating and inspiring atmosphere in Lindau and to fruitful discussions with like-minded young scientists. I am convinced this event will help me to plan my next upcoming career step: a postdoctoral stay abroad.

Are there any Nobelists whom you are particularly excited to meet?
Aaron Ciechanover and Richard Ernst. It will be exciting to meet a Nobelist who does research in a field that is very close to my own project. I am looking forward to Aaron Ciechanover’s talk about drug development in the 21st century. Richard Ernst made outstanding contributions to the field of nuclear magnetic resonance spectroscopy—an analytic tool I use every day for determining the structure of synthetic compounds and macromolecules such as proteins.

 

« Previous 15. Vijay Chudasama

30 Under 30: Lindau Nobel Laureate Meeting

Next » 17. Magnus Johnson

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe